Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cardiovascular & Hematological Disorders Drug Targets|April 12, 2014
Prevention of sudden cardiac death in hemodialysis patientsMichelle M O'Shaughnessy, John A O'Regan, Peter J LavinCurrent Opinion in Nephrology and Hypertension|July 29, 2008
Therapeutic targets in focal and segmental glomerulosclerosisPeter J Lavin, Rasheed Gbadegesin, Tirupapuliyur V Damodaran, et al.Clinical Kidney Journal|June 9, 2016
Kidney transplant outcomes in familial C3 glomerulopathyLimy Wong, Sarah Moran, Peter J Lavin, et al.Pediatric Nephrology (Berlin, Germany)|November 1, 2008
Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGSRasheed Gbadegesin, Bartlomiej Bartkowiak, Peter J Lavin, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2011
Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vectorXiaoyan Luo, Gentzon Hall, Songtao Li, et al.Critical Care (London, England)|December 21, 2021
Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF)Marcus Kirwan, Reema Munshi, Hannah O'Keeffe, et al.Kidney International|August 26, 2011
Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosisRasheed A Gbadegesin, Peter J Lavin, Gentzon Hall, et al.Journal of the American Society of Nephrology : JASN|May 26, 2012
A hybrid CFHR3-1 gene causes familial C3 glomerulopathyTalat H Malik, Peter J Lavin, Elena Goicoechea de Jorge, et al.Journal of the American Society of Nephrology : JASN|January 25, 2011
TRPC6 enhances angiotensin II-induced albuminuriaJason Eckel, Peter J Lavin, Elizabeth A Finch, et al.Kidney International|November 1, 2013
C3 glomerulopathy: consensus reportMatthew C Pickering, Vivette D D'Agati, Carla M Nester, et al.Pageof 2